SECURITY LINE PERFORMANCE ANALYSIS: Lifeline Biotechnologies (OTC: LLBO):
Lifeline Biotechnologies (OTC: LLBO) the stock changed $ -0.0001 and moved -2.14% while the share price hit $ 0.0027 in the last trading session. 3335000 shares traded by hand while it is an average volume with 228,280 shares. The company recorded a relative volume of 1.46. Volume indicators are widespread tools among traders because they can help confirm if other investors agree with your security perspective. Traders generally watch the volume increase as an identified trend gains momentum. The big peaks suggest that the stock has gained a lot of attention from the commercial community and that the shares are under accumulation or distribution. A sudden drop in volume may suggest that traders are losing interest and that an inversion may be coming.
.
Lifeline Biotechnologies (OTC: LLBO)
By monitoring the last 52 weeks, the high price of shares at 52 weeks was observed at $ 0.0035 and the minimum at 52 weeks seen at $ 0. The 50 SMA is $ 0.002703 and 200 SMA is $ 0.002447. Moving averages can be used as support or resistance when a trader looks for a possible entry or exit on the market. This can also be said in the following way. In the event that the price makes a contact with the moving average on the price table, the trader, examining this chart carefully, will enter a long position or a short position. In reality, this works the same way as horizontal support or resistance lines. Moving averages are known as dynamic support and resistance, simply because they tend to change with prices.
The company's net income is $ -574268. Net income available to common stockholders equals net income minus the privileged dividends paid. The net profits available to the common shareholders are the remaining profits after the company pays all its suppliers, employees, service providers, creditors and preferred shareholders. In other words, it's all revenue minus all your favorite expenses and dividends. The number measures the credit of the common shareholders on the company's cash flows.
Return on invested capital (ROCE) is -9.23%. Return on investment (ROCE) is a financial report that measures the profitability of a company and the efficiency with which its capital is used. The return on invested capital (ROCE) is the total amount of capital that a company has used to generate profits. It is the sum of the net assets and liabilities of the debt. It can be simplified as a total of assets minus current liabilities.
The current ratio is 8.424. The current relationship is the classic measure of liquidity. Indicates if the company can pay the debts due within one year from current assets. The quick report is 8.424. 1: 1 shows that the company can meet its current financial obligations with quick funds at hand. A ratio of less than 1: 1 could indicate that the company relies too much on inventory or other assets to pay off its short-term liabilities.
The debt / equity shows a value of 7.885. The D / E ratio is calculated by dividing the total liabilities of a company by its own share capital. In general, a high debt / capital ratio means that a company may not be able to generate enough money to meet its debt obligations. However, low debt / capital ratios may also indicate that a company is not exploiting the greater profits that leverage can bring.
The value of the equity beta was observed at -1.371918. Beta measures the amount of market risk associated with market trading. The high beta reveals more riskiness and the low beta shows a low risk.
PROFITABILITY REPORT:
Monitoring of profitability control, company profit margin recorded at 0.00% and operating margin at 0.00%. The corporate ownership of the company is 0.00% while the insider property is 0.00%.
VALIDATION OBSERVATIONS:
Headquarters Location of Lifeline Biotechnologies (OTC: LLBO) is United States. The P / B ratio is 1.4. P / B is used to compare the market value of a security with its book value. It has a market capitalization of $ 9376976. Using market capitalization to show the size of a company is important because the size of the company is a basic determinant of various characteristics in which investors are interested, including the risk .
TECHNICAL INDICATORS:
Now the company has an RSI figure of 0. RSI compares the entity of recent gains with recent losses to see if an asset is oversold or overbought. RSI is plotted on a scale of 0 to 100. Generally, if it is above 70, the stock is considered overbought and then you can try to sell it. Similarly, an RSI below 30 indicates that the stock is oversold and can be purchased.
ADX value listed at 100. ADX is best used for screening stocks and write scans. By adding this indicator to the scanning software, it is possible to eliminate all the stocks that are in the trading ranges. You can then set the scan to find only stocks with a sharp uptrend or strong downtrend.
So what is the ADX indicator for?
The ADX indicator does not provide signals of purchase or sale. However, it gives you some perspective on where the title is in the trend. Low readings and you have a trading interval or the beginning of a trend. Extremely high readings indicate that the trend will probably end.
David Culbreth – Category – Business
David Culbreth he is a self-taught investor who has invested in equities since he was a college senior and continues to invest. He is extremely devoted to demystifying the investment terminology for new investors.
David Culbreth is a senior author and journalist. Has more than 5 years experience in institutional investment markets, including fixed income securities, equities, derivatives and real estate. David holds a Bachelor's degree in Business Administration with a specialization in Finance. He bought his first titles in a private company at the age of 15 and made his first public stock market at 23. He has always been interested in the stock market and how it behaves.
As a father of two, he saved money and invested a high priority for them. Over many years of investment, he made wise choices and made many mistakes. But he learned from both. David David's observations and experience provide him with insight into the stock exchange models and behaviors of the investors who create them.
